Study ID: IXL-201-14-189

Study Title

Multicenter Trial for Adults With Partial Seizures

Teva Identifier

IXL-201-14-189

ClinicalTrials.gov Identifier

NCT00034814

Study Status

Completed

Trial Condition(s)

Epilepsy

Interventions

Drug: Talampanel | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
neurology icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years to 65 Years

Trial Duration

01/01/2002 - 01/01/2006

Phase

Phase 2

Study Type

Interventional